Robert D Auerbach Net Worth

The estimated Net Worth of Robert D Auerbach is at least $1.88 Million dollars as of 1 February 2021. Robert Auerbach owns over 592 units of Cooper Companies stock worth over $330,738 and over the last 6 years Robert sold COO stock worth over $1,552,224.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Robert Auerbach COO stock SEC Form 4 insiders trading

Robert has made over 8 trades of the Cooper Companies stock since 2019, according to the Form 4 filled with the SEC. Most recently Robert exercised 592 units of COO stock worth $64,238 on 1 February 2021.

The largest trade Robert's ever made was exercising 5,326 units of Cooper Companies stock on 1 April 2019 worth over $875,062. On average, Robert trades about 1,607 units every 69 days since 2018. As of 1 February 2021 Robert still owns at least 3,048 units of Cooper Companies stock.

You can see the complete history of Robert Auerbach stock trades at the bottom of the page.

What's Robert Auerbach's mailing address?

Robert's mailing address filed with the SEC is C/O THE COOPER COMPANIES, INC., 6101 BOLLINGER CANYON ROAD, SUITE 500, SAN RAMON, CA, 94583.

Insiders trading at Cooper Companies

Over the last 21 years, insiders at Cooper Companies have traded over $45,273,696 worth of Cooper Companies stock and bought 5,157 units worth $1,262,486 . The most active insiders traders include Robert S Weiss, William A Kozy, and Lawrence Erik Kurzius. On average, Cooper Companies executives and independent directors trade stock every 18 days with the average trade being worth of $1,325,775. The most recent stock trade was executed by Brian G Andrews on 5 September 2024, trading 24,788 units of COO stock currently worth $939,713.

What does Cooper Companies do?

company overview the cooper companies, inc. ("cooper"​) is a global medical device company publicly traded on the nyse euronext (nyse:coo). cooper is dedicated to being a quality of life company™ with a focus on delivering shareholder value. cooper operates through two business units, coopervision and coopersurgical. coopervision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. coopersurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. headquartered in pleasanton, ca, cooper has approximately 9,000 employees with products sold in over 100 countries. for more information, please visit www.coopercos.com.

Complete history of Robert Auerbach stock trades at Cooper Companies

Cooper Companies executives and stock owners

Cooper Companies executives and other stock owners filed with the SEC include:

• Albert White,
  President, Chief Executive Officer, Director
• Daniel McBride,
  Chief Operating Officer, Executive Vice President, President of CooperVision, Inc.
• Holly Sheffield,
  President - CooperSurgical
• Brian Andrews,
  Chief Financial Officer, Senior Vice President, Treasurer
• Albert G. White III,
  Pres, CEO & Non-Independent Director
• Agostino Ricupati,
  Senior Vice President - Finance and Tax, Chief Accounting Officer
• Daniel G. McBride Esq.,
  Exec. VP & COO
• Holly R. Sheffield,
  Pres of CooperSurgical, Inc.
• Brian G. Andrews,
  Exec. VP, CFO & Treasurer
• A. Thomas Bender,
  Independent Chairman of the Board
• Allan Rubenstein,
  Independent Vice Chairman of the Board, Lead Director
• Jody Lindell,
  Independent Director
• Gary Petersmeyer,
  Independent Director
• Colleen Jay,
  Independent Director
• William Kozy,
  Independent Director
• Robert Weiss,
  Director
• Teresa Madden,
  Independent Director
• Kim Duncan,
  Vice President of Investor Relations and Administration
• Randal Golden,
  Vice President, General Counsel, Secretary
• Juan Carlos Aragón,
  Pres of CooperVision Specialty EyeCare Division
• Mark J. Drury,
  VP, Gen. Counsel & Corp. Sec.
• Agostino Ricupati,
  Sr. VP of Fin. & Tax and Chief Accounting Officer
• Carol R Kaufman,
  VP Legal Affairs, Sec. and CAO
• Paul L Remmell,
  COO, VP Finance-CSI
• Tina Maloney,
  Corporate Controller
• Gregory W Matz,
  VP & CFO
• Stanley Md Zinberg,
  Director
• Michael Kalkstein,
  
• Nicholas J Pichotta,
  
• Rodney Folden,
  Corporate Controller
• Donald Press,
  Director
• Steven Rosenberg,
  Director
• Jeffrey Alan Mc Lean,
  Pres - U.S. Ops - CVI
• Dennis Murphy,
  President Americas, CVI
• Moses Marx,
  Director
• Andrew Sedgwick,
  Managing Dir., Europe of CVI
• Eugene J Midlock,
  Vice President, Taxes
• John J Calcagno,
  CFO and VP Bus. Dev.
• John Arthur Weber,
  Vice Pres Worldwide Ops-CVI
• J Christopher Marmo,
  VP, R&D of CooperVision, Inc.
• John D Fruth,
  Director
• B Norris Battin,
  
• Edgar J Cummins,
  Director
• Steven M Neil,
  CFO
• David Acosta,
  Treasurer
• Companies Inc Cooper,
  Director
• Gregory A Fryling,
  COO - CVI
• James M Welch,
  Vice President Intl Ops - CVI
• Stephen Whiteford,
  VP, Corporate Controller
• Robert D Auerbach,
  Special Advisor to the CEO
• Mark J Drury,
  VP, General Counsel & Sec.
• Maria Rivas,
  
• Gerard H Iii Warner,
  President, CooperVision, Inc.
• Nicholas Khadder,
  VP, General Counsel & Corp Sec
• Lawrence Erik Kurzius,
  
• Cynthia L Lucchese,